About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Fen1tm2.1Bhsh
targeted mutation 2.1, Binghui Shen
MGI:5629667
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Fen1tm2.1Bhsh/Fen1tm2.1Bhsh involves: 129S1/Sv MGI:5694452
ht2
Fen1tm2.1Bhsh/Fen1+ involves: 129S1/Sv MGI:5694455


Genotype
MGI:5694452
hm1
Allelic
Composition
Fen1tm2.1Bhsh/Fen1tm2.1Bhsh
Genetic
Background
involves: 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fen1tm2.1Bhsh mutation (0 available); any Fen1 mutation (30 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• between 14 and 20 months of age, homozygotes exhibit a higher spontaneous tumor incidence than wild-type controls
• overall, 38 of 51 (74.5%) homozygotes developed various types of tumors relative to only 9 of 51 (17.6%) wild-type mice which only developed lung tumors
• 4 of 51 (7.8%) homozygotes developed spleen tumors
• 1 of 51 (2%) homozygotes developed a thymus tumor
• 4 of 51 (7.8%) homozygotes developed liver tumors
• 29 of 51 (56.9%) homozygotes developed lung tumors

cellular
• average % of near-tetraploid aneuploidy in mutant MEFs cells is 14.5% relative to 6.6% in wild-type MEFs
• FISH analysis revealed that spontaneous telomere fragility is 1.5-fold higher in mutant MEFs (4.3%) relative to wild-type MEFs (2.7%), with one fragile telomere occurring per 23 telomeres versus 37 telomeres in wild-type cells
• telomere fragility on the lagging strand is 2.3% in mutant MEFs relative to 1.2% in wild-type MEFs, whereas fragility on the leading strand is 0.5% in mutant and 0.15% in wild-type MEFs
• telomere loss for lagging strands is 0.85% in mutant MEFs and 0.45% in wild-type MEF), whereas telomere loss in leading strands is 0.75% in mutant and 0.3% in wild-type MEFs
• in vitro cellular transformation assays revealed that the number of colonies formed by mutant MEFs is 9-fold higher than in wild-type MEFs, indicating a high transformation potential
• under normal culture conditions, mutant MEFs show mild-to-moderate defects in cell growth relative to wild-type MEFs
• upon treatment with camptothecin (CPT), a chemical reagent that causes stall of DNA replication forks in cells, the number of mutant live cells is decreased by 3% per day, whereas the number of wild-type cells is increased by 10% per day
• in response to UV and camptothecin (CPT) treatment, mutant MEFs isolated from E13 embryos accumulate significantly more double-strand DNA breaks than wild-type MEFs, as determined by gammaH2AX staining
• however, untreated wild-type and mutant MEFs show little or no positive gammaH2AX staining
• mutant MEFs exhibit significantly more spontaneous chromosome breaks (2.0%) than wild-type MEFs (0.6%)

homeostasis/metabolism
• in response to UV and camptothecin (CPT) treatment, mutant MEFs isolated from E13 embryos accumulate significantly more double-strand DNA breaks than wild-type MEFs, as determined by gammaH2AX staining
• however, untreated wild-type and mutant MEFs show little or no positive gammaH2AX staining

respiratory system
• 29 of 51 (56.9%) homozygotes developed lung tumors

endocrine/exocrine glands
• 1 of 51 (2%) homozygotes developed a thymus tumor

liver/biliary system
• 4 of 51 (7.8%) homozygotes developed liver tumors




Genotype
MGI:5694455
ht2
Allelic
Composition
Fen1tm2.1Bhsh/Fen1+
Genetic
Background
involves: 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fen1tm2.1Bhsh mutation (0 available); any Fen1 mutation (30 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• average % of near-tetraploid aneuploidy in heterozygous mutant MEFs cells is 9.6% relative to 6.6% for wild-type MEFs
• under normal culture conditions, heterozygous mutant MEFs show mild-to-moderate defects in cell growth relative to wild-type MEFs
• upon treatment with camptothecin (CPT), the number of heterozygous mutant live cells is increased by only 1.7% per day, whereas the number of wild-type cells is increased by 10% per day
• heterozygous mutant MEFs exhibit significantly more spontaneous chromosome breaks (1.0%) than wild-type MEFs (0.6%)





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory